Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has The mRNA Therapeutics Market Size Shifted, And What Is the Outlook Through 2034?
In the past few years, the mRNA therapeutics market size has seen consistent growth. The market is projected to expand from $34.76 billion in 2024 to $36.25 billion in 2025, with a compound annual growth rate (CAGR) of 4.3%. The notable growth during the historical timeframe can be credited to factors such as robust financial backing for the development of effective drugs and vaccines, the growth of government initiatives aimed at advancing RNA-based treatments, increased awareness about rare genetic disorders, and a surge in clinical trial numbers.
How Much Will the mRNA Therapeutics Market Be Worth in 2029?
Anticipations are for the mRNA therapeutics market size to see consistent growth over the next few years. The market is projected to expand to $42.23 billion by 2029, with a compound annual growth rate (CAGR) of 3.9%. Reasons for this expected growth during the forecast period include the surging number of infectious diseases, rising patient count in hospitals and clinics, broadening scope of mRNA therapeutics, growing need for tailor-made and precision medicine, advantageous regulatory contexts, and quickened approval routes. Key trends during the forecast timeframe are progress in mRNA delivery techniques, swift evolution and adoption of mRNA vaccines, the arrival of self-amplifying mRNA (saRNA) platforms, the scalability and adaptability of mRNA production, and the creation of innovative mRNA modifications.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17205&type=smp
Which is the Largest Company in the mRNA Therapeutics Market?
Major companies operating in the mRNA therapeutics market are Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd, Tiba Biotech LLC, CSPC Pharmaceutical Group, CRISPR Therapeutics AG
What Are the Main Market Drivers in the mRNA Therapeutics Industry?
The rise in chronic and communicable disease prevalence is anticipated to spur the mRNA therapeutics market’s growth. These diseases, including tuberculosis, HIV/AIDS, and hepatitis, last for long durations and can be spread from one person to another. Increased global travel and insufficient healthcare infrastructure contribute to the growing incidence of these diseases, as they enable disease transmission and impede effective disease management. mRNA therapies are beneficial for chronic and communicable diseases because they quickly allow the body to generate proteins that stimulate immune responses. This leads to a faster pace of vaccine and treatment creation. For example, GOV.UK stated in October 2023 that the number of individuals in England diagnosed with HIV and receiving treatment in 2022 was 94,397, a 3% increase from the 91,368 individuals in 2021. As such, the rise of chronic and communicable diseases is fueling the mRNA therapeutics market’s growth.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=17205&type=smp
How Is the mRNA Therapeutics Market Segments Structured?
The mRNA therapeutics market covered in this report is segmented –
1) By Product: Vaccines, Drugs
2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications
3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses
Subsegments:
1) By Vaccines: Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines
2) By Drugs: Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs
What Strategic Trends Are Transforming the mRNA Therapeutics Market?
Key players in the market for mRNA therapeutics are placing emphasis on the development of innovative solutions such as mRNA-based booster vaccines, designed to bolster immunity against mutating viral variants. mRNA booster vaccines employ messenger RNA technology to enhance and extend the immune response to a specific pathogen, typically after the initial round of vaccinations has occurred. For example, Gennova Biopharmaceuticals Ltd., a pharmaceutical company rooted in India, introduced the country’s first locally-produced mRNA booster vaccine designed specifically to address the Omicron variant of SARS-CoV-2 in June 2023. This vaccine, named GEMCOVAC-OM, was devised to generate an effective immune response against the variant. Notably, GEMCOVAC-OM boasts thermostability, it doesn’t necessitate an ultra-cold chain infrastructure and its administration doesn’t rely on needles as it employs a needle-free device system. These qualities make it particularly suitable for deployment in remote parts of India. Clinical trials showed GEMCOVAC-OM producing immune responses of significantly higher levels than other vaccines, accentuating the importance of variant-specific vaccines in generating optimal immune responses.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report
Which Global Regions Offer the Highest Growth in the mRNA Therapeutics Market?
North America was the largest region in the mRNA therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17205
This Report Delivers Insight On:
1. How big is the mrna therapeutics market, and how is it changing globally?
2. Who are the major companies in the mrna therapeutics market, and how are they performing?
3. What are the key opportunities and risks in the mrna therapeutics market right now?
4. Which products or customer segments are growing the most in the mrna therapeutics market?
5. What factors are helping or slowing down the growth of the mrna therapeutics market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model